Metachromatic Leukodystrophy
Commons · Question 5800 · Tabled 1 Jun 2026 · Department of Health and Social Care · Official record
Answered 1 Jul 2026
Question
Asked by Gregory Stafford
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of adding metachromatic leukodystrophy (MLD) to the NHS newborn blood spot screening programme.
Answer
Answered by Sharon Hodgson, 1 Jul 2026
Members of the UK National Screening Committee (UK NSC) have agreed that metachromatic leukodystrophy (MLD) would be a good candidate for the inclusion in a multi-condition in-service evaluation (ISE) within the United Kingdom’s newborn blood spot (NBS) s...